WE KNOW HOW TO TELL IT

San Carlos, CA

Allakos is a clinical-stage company developing antibodies that target receptor molecules present on the surface of immune effector cells involved in allergy, inflammation and tissue damage.

Houston, TX
 

Aravive is developing novel cancer therapeutics that spare healthy cells while targeting tumor adaptive responses and cancer evasion pathways. The company's primary therapeutics focus is the GAS6-AXL pathway, whereby they can interrupt oncogenic signals and turn off the "survival switch" that allows cancer to grow, spread, and acquire therapeutic resistance. 

Paris, France

Bionest works to create competitive advantage for its clients by developing innovative and differentiated strategies at the corporate, portfolio and brand levels of medical and life science businesses. They also provide valuation and due diligence services to companies, investors and private equity.

Vancouver, WA

CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of Human Immunodeficiency Virus (HIV) infection. Their lead product candidate, Pro140, is the first self-administered antibody in late-stage clinical trials and works by blocking HIV from entering cells.

Louisville, KY
 

Eurofins Genomics company is an international provider of DNA sequencing services, genotyping services, DNA synthesis products, and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological, and research markets. Eurofins Genomics operates leading R&D and production sites in the USA, Canada, Germany, India, and Japan. Eurofins Genomics is the genomic services brand of the Eurofins Group, the worldwide leader in food, environmental and pharmaceutical testing.

Sunnyvale, CA

Labcyte is revolutionizing liquid handling. Its Echo liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical industry, diagnostic companies, genome centers, genomic service companies, biotechnology firms, contract research organizations, and academic institutions.

Austin, Tx

Luminex aims to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers.

San Rafael, CA

MedCision is the world leader in next-generation automated cell thawing for advanced therapies. The company develops and commercializes technologies that automate and standardize vital preclinical and clinical biologics handling for critical post-manufacturing processes.

Mountain View, CA

Osel, Inc. is pioneering a new class of medicine called Live Biotherapeutic Products (LBPs) that modulate the body’s natural microbiome to restore health and prevent infection. In 2003, Osel was one of the first companies to receive FDA authorization to test a live bacterial therapeutic, and is a pioneer in the field of LBPs. Women's health is their unique focus.

Wellesley, Mass and Reston, VA

Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the life sciences, healthcare services and technology markets with a value-added client-centric approach to merger, acquisition and corporate finance advisory services.

Menlo Park, CA

Pacific Biosciences in transforming the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.

Redwood City, CA

Ingenuity Systems is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems.

Beverly, MA

Sage Science develops products for sale to the Life Sciences research and Diagnostic laboratory markets. The company's mission is to provide new systems to streamline and improve sample preparation workflows.

Santa Cruz, CA

Two Pore Guys (2PG) develops single-molecule sensing technologies that employ solid-state nanopores and biochemical reagents to create a versatile sample-in/results-out detection platform. 2PG’s first product is a handheld device that can use reagents from existing molecular or analyte diagnostic assays and provide accuracy and sensitivity rivaling sophisticated laboratory equipment.

San Francisco, CA

Xcell is developing revolutionary products and workflows for life science and translational research that reproduce physiologically relevant conditions to enable more meaningful, biologically relevant experiments. The company’s tools empower scientists to obtain accurate and actionable results in important fields such as cancer research, biomarker discovery, lead candidate selection and optimization, stem cell research and regenerative medicine, and immunotherapy drug development.

Association for Molecular Pathology, Applied Biosystems, BD Biosciences, Benchling, Biotique Systems, Cellular Resarch (purchased by BD) Chiron Corporation, Connetics Corporation, Cynvenio Biosystems, DNAnexus, DoubleTwist, Eos, GE healthymagination, Gen9, Genentech, GenoSpectra, IntegenX, Invitrogen, Microsoft Health Solutions, Medtronic, Mohr Davidow Ventures, NanoString Technologies, Nektar, NIST: Multiplexed Biomolecular Science Group, Omicia, PAG, PaxVax, Personalis, RainDance Technologies, StationX, Varian Medical Systems, VitaPath Genetics, Zyomyx